A Prospective Trial of Cooled Radiofrequency Ablation of Medial Branch Nerves Versus Facet Joint Injection of Corticosteroid for the Treatment of Lumbar Facet Syndrome
1 other identifier
interventional
39
1 country
1
Brief Summary
Chronic, non-neurogenic low back pain (CLBP) is a common condition that affects many individuals across their lives. The lumbar facet joint has been implicated as an important source of CLBP, with a prevalence of 15-45%. Elements of clinical history, physical examination, and imaging (radiographs, standard CT scan, standard MRI sequences) provide poor diagnostic specificity for pain of lumbar zygapophysial joint (Z-joint) origin. Thus, clinicians have traditionally relied upon MBN blocks to confirm or refute this diagnosis. The reference standard for the diagnosis of lumbar Z-joint pain is a positive response to dual comparative MBN blocks, which requires pain reduction of great than or equal to 80% of concordant duration to that expected of two different local anesthetics on independent occasions. Further, dual comparative MBN blocks have a high positive predictive value for determining the clinical outcome of lumbar MBN RFA for the treatment of lumbar Z-joint pain; when patients are appropriately selected using this reference standard and rigorous MBN RFA technique is implemented according to practice guidelines, studies demonstrate excellent clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 12, 2018
CompletedFirst Posted
Study publicly available on registry
August 3, 2018
CompletedStudy Start
First participant enrolled
October 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 18, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 18, 2023
CompletedResults Posted
Study results publicly available
July 16, 2024
CompletedJuly 16, 2024
July 1, 2024
5 years
July 12, 2018
January 18, 2024
July 12, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Numeric Pain Rating Scale (NPRS)
This is a scale from 0 to 10, with 0 being no back pain at all and 10 being the worst back pain imaginable The primary outcome for this study was the proportion of participants within each group (C-RFA and FJI) who experienced a greater than or equal to 50% reduction in NPRS score at 3 months. Participants were asked to rate their pain over the past 7 days on a scale from 0 to 10.
3 Months
Secondary Outcomes (5)
Decrease in Oswestry Disability Index (ODI) Score
6 Months
Patient Global Impression of Change (PGIC)
6 Months
Numeric Pain Rating Scale (NPRS) Point Change
6 Months
Global Impression of Change (PGIC)
2 year
Adverse Events
2 year
Study Arms (2)
Cooled Radiofrequency Ablation Procedure
ACTIVE COMPARATORCooled Radiofrequency Ablation (C-RFA) Procedure: This is performed under image (x-ray) guidance for the accuracy of needle placement. A Cooled Radiofrequency electrode will be placed at the surface of the facet joint. After appropriate electrode positioning, a local anesthetic (lidocaine) will be injected through the needle to take away pain during the ablation. Once the procedure is completed, all needles will be removed and additional local anesthetic (bupivacaine) will be injected. No corticosteroids will be injected.
Facet Joint Inject Procedure
ACTIVE COMPARATORFacet joint injection (FJI) Procedure: This is performed under image guidance (x-ray) for the accuracy of needle placement. A needle will be carefully placed in the facet joint(s) causing pain. Contrast will be injected to confirm the ideal needle placement. The injection will then be completed with triamcinolone (steroid) and lidocaine. This technique will be repeated for each facet joint injected. For bilateral low back pain, a maximum of 4 facet joints (two on each side) will be treated. For unilateral low back pain, up to 3 facet joints will be treated.
Interventions
Radio frequency ablation (RFA) is a medical procedure in which heat is generated from high frequency electrical current in order to lesion (burn) nervous tissue.
Eligibility Criteria
You may qualify if:
- Adult patients aged \> 21 capable of understanding and providing consent in English and capable of complying with the outcome instruments used.
- Axial (non-radicular) back pain for at least 3 months (ie Chronic Low Back Pain), with pain lasting at least half of the days within those 3 months, that did not respond to conventional treatment such as physical therapy, oral analgesic agents, and non-invasive adjunctive treatments. The pain can be unilateral or bilateral. The pain can also include referred lower limb pain.
- day worst numeric pain rating score (NPRS) for back pain of 5/10 or greater at baseline evaluation.
- Positive responses to dual comparative diagnostic MBN blocks using 0.5mL of 0.5% bupivacaine and 4% lidocaine, on respective encounters on separate days, at each of the appropriate MBNs. The blocks are administered in a double-blind fashion so that neither the subject nor the independent assessor is aware of the local anesthetic used.
You may not qualify if:
- Focal neurologic signs or symptoms.
- Radiologic evidence of a symptomatic herniated disc or nerve root impingement related to spinal stenosis.
- Active systemic or local infections at the site of proposed needle and electrode placement.
- Coagulopathy or other bleeding disorder.
- Receipt of remuneration for their pain treatment (e.g. disability, worker's compensation, auto injury in litigation or pending litigation).
- History of any lumbar or lower thoracic fusion surgery or placement of other hardware.
- \> Grade 2 Spondylolisthesis at an affected or adjacent level.
- Cobb angle \>10 degrees.
- Sagittal vertical axis angle \>5 degrees
- BMI \>40.
- Incarceration.
- Cognitive deficit affecting ability to complete the assessment instruments.
- Inability to read English and complete the assessment instruments.
- Allergy to local anesthetics.
- Chronic widespread pain or somatoform disorder (e.g. fibromyalgia).
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Utah Orthopaedic Center
Salt Lake City, Utah, 84108, United States
Related Publications (1)
McCormick ZL, Conger A, Kendall R, Wagner G, Henrie AM, Littell M, Sperry BP, Petersen R, Cooper AN, Teramoto M, Burnham TR. A pragmatic randomized prospective trial of cooled radiofrequency ablation of the medial branch nerves versus facet joint injection of corticosteroid for the treatment of lumbar facet syndrome: 12 month outcomes. Pain Med. 2023 Dec 1;24(12):1318-1331. doi: 10.1093/pm/pnad107.
PMID: 37578437DERIVED
Results Point of Contact
- Title
- Zachary McCormick, MD
- Organization
- University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Spine and Pain Medicine Director, Clinical Spine Research Director, Interventional Spine and Musculoskeletal Medicine Fellowship, Division of Physical Medicine and Rehabilitation University of Utah School of Medicine
Study Record Dates
First Submitted
July 12, 2018
First Posted
August 3, 2018
Study Start
October 1, 2018
Primary Completion
September 18, 2023
Study Completion
September 18, 2023
Last Updated
July 16, 2024
Results First Posted
July 16, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL